CTBO (Cantabio Pharmaceuticals) Total Stockholders Equity: $-1.89 Mil (As of Dec. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cantabio Pharmaceuticals Total Stockholders Equity?

Cantabio Pharmaceuticals CTBO Total Stockholders Equity is $-1.89 Mil as of Dec. 2018.

Cantabio Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Dec. 2018 was $-1.89 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cantabio Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2018 was $-99.42. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cantabio Pharmaceuticals's Debt-to-Equity for the quarter that ended in Dec. 2018 was -0.75.

Cantabio Pharmaceuticals  (OTCPK:CTBO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cantabio Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2018 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-1.889-0)/0.019
=-99.42

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cantabio Pharmaceuticals's Debt-to-Equity for the quarter that ended in Dec. 2018 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.409 + 0) / -1.889
=-0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Total Stockholders Equity Related Terms

Cantabio Pharmaceuticals Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Total Stockholders Equity Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Total Stockholders Equity
Get a 7-Day Free Trial -0.00 -0.22 -0.37 -0.85 -1.87

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.80 -1.87 -2.30 -2.42 -1.89
What does a Total Stockholders Equity of $-1.89 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Total Stockholders Equity of $-1.89 Mil as of Dec. 2018. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Total Stockholders Equity too high?
Cantabio Pharmaceuticals' current Total Stockholders Equity is $-1.89 Mil.
How does Cantabio Pharmaceuticals' Total Stockholders Equity compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Total Stockholders Equity of $-1.89 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Total Stockholders Equity is $-1.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Total Stockholders Equity of $-1.89 Mil. The current Total Stockholders Equity is $-1.89 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Total Stockholders Equity is $-1.89 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.